Individual Study / Hall_Br J Cancer_1991

Hall_Br J Cancer_1991

Hall_Br J Cancer_1991

Initiatives -
The present study was designed to evaluate the risk of second primary cancer in a cohort of thyroid cancer patients treated with Iodine 131, and to contrast the risk with that of nonexposed thyroid cancer patients. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
1950
End Year
1975

Members

Download
Investigators Contacts
  • Dr. Prof. Per Hall
    Karolinska Institutet

Design

Study design
Clinical trial cohort
Follow Up
Observation period was 10 years or more.

Marker Paper

Hall, P., Holm, LE., Lundell, G. et al. Cancer risks in thyroid cancer patients. Br J Cancer 64, 159–163 (1991). https://doi.org/10.1038/bjc.1991.261

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
1,995
Number of participants with biosamples
Supplementary Information
Thyroid cancer patients under 76 years old.

Access

Availability of data and biosamples

Data
Biosamples
Other